1-3 of 3
Michelle Coulson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase 1 Study of PIT565, a First-in-Class, Anti-CD3, Anti-CD19, Anti-CD2 Trispecific Antibody in Patients with Relapsed and/or Refractory B-Cell Malignancies

Irit Avivi Mazza, Pere Barba, Junichiro Yuda, Maria Lia Palomba, Juan Pablo Alderuccio, Ciel De Vriendt, Paolo Corradini, Francesca Lorraine Wei Inng Lim, Pier Luigi Zinzani, Nitin Jain, Jessica T. Leonard, Michelle Coulson, Nadia Hassounah, Xiaoling Yang, Haihui Lu, Andrew Lewandowski, Joseph Ryan Polli, Matthieu Klopfenstein, Alessandro Pastore, Gabriel Brisou
Journal: Blood
Blood (2023) 142 (Supplement 1): 3099.
https://doi.org/10.1182/blood-2023-179061
Published: 2023
Journal Articles

PIT565, a First-in-Class Anti-CD19, Anti-CD3, Anti-CD2 Trispecific Antibody for the Treatment of B Cell Malignancies

Haihui Lu, Adwait Oka, Michelle Coulson, Joseph Ryan Polli, Kimberly Aardalen, Melissa Ramones, Dana B Walker, Ana Carrion, Dylan Alexander, Matthieu Klopfenstein, Masaki Akiyama, Francesca Rucci, Brian Granda, Alessandro Pastore
Journal: Blood
Blood (2022) 140 (Supplement 1): 3148.
https://doi.org/10.1182/blood-2022-168904
Published: 2022
Journal Articles

A Novel Antibody-Drug Conjugate Targeting CCR7 in Hematologic Malignancies

Anhthu Dang, Deborah Knee, Cui Ying Wang, Feng Gao, Guoxun Liu, Sergio Briones, Michelle Coulson, Jessica Makofske, Keith Mansfield, May Liu, Tanya Mulvey, Emily K Meseck, Steve Woolfenden, Sean G Buchanan, David Steensma, Vasileios Askoxylakis
Journal: Blood
Blood (2022) 140 (Supplement 1): 11564–11565.
https://doi.org/10.1182/blood-2022-159910
Published: 2022